Parion Sciences

Parion Sciences is a development-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies to improve and extend the lives of patients with serious respiratory diseases. Parion has a range of preclinical and clinical candidates that treat these diseases through unique mechanisms of action and approaches. Parion is at the forefront of ENaC development and leverages our scientific expertise in epithelial biology to expand our platform and apply novel compounds to people suffering from mucus-obstructive respiratory diseases such as chronic obstructive pulmonary disease, primary ciliary dyskinesia, bronchiectasis, severe asthma, and pulmonary viral infections.